Hennessy M, Wahba A, Felix K, Cabrera M, et al. Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent and in combination with checkpoint-inhibitor therapy in mouse models of osteosarcoma. Int J Cancer 2021;148:1928-1937.
PMID: 33152115